These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19330836)

  • 21. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
    Okada K; Moon HJ; Finney J; Meier A; Mure M
    Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.
    Akiri G; Sabo E; Dafni H; Vadasz Z; Kartvelishvily Y; Gan N; Kessler O; Cohen T; Resnick M; Neeman M; Neufeld G
    Cancer Res; 2003 Apr; 63(7):1657-66. PubMed ID: 12670920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
    Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
    Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levoleucovorin inhibits LOXL2 (lysyl oxidase like-2) to control breast cancer proliferation: a repurposing approach.
    Deshpande H
    J Biomol Struct Dyn; 2024 Jul; 42(10):5104-5113. PubMed ID: 37340696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LOXL2 in epithelial cell plasticity and tumor progression.
    Cano A; Santamaría PG; Moreno-Bueno G
    Future Oncol; 2012 Sep; 8(9):1095-108. PubMed ID: 23030485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
    Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization.
    Canesin G; Cuevas EP; Santos V; López-Menéndez C; Moreno-Bueno G; Huang Y; Csiszar K; Portillo F; Peinado H; Lyden D; Cano A
    Oncogene; 2015 Feb; 34(8):951-64. PubMed ID: 24632622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma.
    Xu J; Li D; Li X; Liu Z; Li T; Jiang P; He Q; Tian F; Gao Y; Wang D; Wang S
    Dig Liver Dis; 2014 Aug; 46(8):750-7. PubMed ID: 24794791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas.
    Moreno-Bueno G; Salvador F; Martín A; Floristán A; Cuevas EP; Santos V; Montes A; Morales S; Castilla MA; Rojo-Sebastián A; Martínez A; Hardisson D; Csiszar K; Portillo F; Peinado H; Palacios J; Cano A
    EMBO Mol Med; 2011 Sep; 3(9):528-44. PubMed ID: 21732535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
    Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM
    Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.
    Martin A; Salvador F; Moreno-Bueno G; Floristán A; Ruiz-Herguido C; Cuevas EP; Morales S; Santos V; Csiszar K; Dubus P; Haigh JJ; Bigas A; Portillo F; Cano A
    EMBO J; 2015 Apr; 34(8):1090-109. PubMed ID: 25759215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
    Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO
    Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.
    Schietke R; Warnecke C; Wacker I; Schödel J; Mole DR; Campean V; Amann K; Goppelt-Struebe M; Behrens J; Eckardt KU; Wiesener MS
    J Biol Chem; 2010 Feb; 285(9):6658-69. PubMed ID: 20026874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The function and mechanisms of action of LOXL2 in cancer (Review).
    Wu L; Zhu Y
    Int J Mol Med; 2015 Nov; 36(5):1200-4. PubMed ID: 26329904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LOXL2 in cancer: regulation, downstream effectors and novel roles.
    Wen B; Xu LY; Li EM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
    Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
    Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
    de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
    J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.